Alternative Names
ANTI-LINGO 1 research-grade biosimilar; ANTI-LINGO-1 research-grade biosimilar; Anti-LINGO-1 antibody research-grade biosimilar; BIIB-033 research-grade biosimilar; Opicinumab research-grade biosimilar; Opicinumab (USAN/INN) research-grade biosimilar; LINGO1 antibody; LERN1 antibody; LRRN6A antibody; UNQ201/PRO227 antibody;Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 antibody; Leucine-rich repeat and immunoglobulin domain-containing protein 1 antibody; Leucine-rich repeat neuronal protein 1 antibody; Leucine-rich repeat neuronal protein 6A antibody
Immunogen
Recombinant Human LINGO1 protein
Immunogen Species
Homo sapiens (Human)
Concentration
It differs from different batches. Please contact us to confirm it.
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.